CLDX Net Income Growth
Celldex Therapeutics Inc · Net Income Growth
CLDX Net Income Growth
Year-over-year change vs the same period a year earlier
Latest reported-29.86%period ending
CLDX Quarterly Net Income YoY % (75.00% → -29.86%)
Year-over-year change
High-resolution chart · PNG
CLDX net income growth history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Net Income Growth |
|---|---|
| -29.864% | |
| -46.2655% | |
| -72.7682% | |
| -59.17% | |
| -57.9153% | |
| -63.9722% | |
| -8.7424% | |
| -10.0915% | |
| -17.507% | |
| -11.7401% | |
| -63.4991% | |
| -42.8465% | |
| 15.2816% | |
| -27.3796% | |
| -31.4622% | |
| -30.9603% | |
| -169.229% | |
| -39.376% | |
| 8% | |
| -43.7852% | |
| -21.2311% | |
| -30.9941% | |
| -109.6296% | |
| -24.6298% | |
| 6.3503% | |
| 26.7649% | |
| -11.1147% | |
| -57.5728% | |
| 28.2075% | |
| 85.407% | |
| -144.78% | |
| 72.5259% | |
| 42.5646% | |
| -244.8002% | |
| 88.1109% | |
| 10.9298% | |
| 10.5971% | |
| 1.1882% | |
| 1.1535% | |
| 7.4484% | |
| 1.2578% | |
| -14.9102% | |
| -2.712% | |
| -13.8808% | |
| -14.4479% | |
| -0.9063% | |
| -44.2344% | |
| -21.357% | |
| -48.6853% | |
| -72.5306% | |
| -31.2667% | |
| -53.9895% | |
| -38.0672% | |
| -28.2332% | |
| -32.006% | |
| -27.6504% | |
| -34.5545% | |
| -34.3672% | |
| -156.1846% | |
| -29.5477% | |
| -7.4646% | |
| -52.8259% | |
| 275.0831% | |
| -26.6657% | |
| -9.4199% | |
| 14.5625% | |
| -73.6565% | |
| 6.2976% | |
| 15.1602% | |
| 65.1892% | |
| -41.8646% | |
| -88.7139% | |
| -272.4138% | |
| -448.8212% | |
| 15.4267% | |
| 26.5108% | |
| 51.4111% | |
| -35.7259% | |
| -56.0942% | |
| -22.287% | |
| -19.7797% | |
| 38.9752% | |
| -7.6088% | |
| -22.1041% | |
| -21.4204% | |
| -154.9753% | |
| 7.734% | |
| -74.7507% | |
| -22.4767% | |
| 43.2098% | |
| -15.3434% | |
| -666.0029% | |
| 38.3595% | |
| 31.5736% | |
| 49.3086% | |
| 95.5623% | |
| 8.7628% | |
| -22.7295% | |
| 49.1971% | |
| -71.2902% |